Evidence map›Paper›PMID 38684032›Full record

ArticleBlood2024

Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells.

Isabella M Mayer, Eszter Doma, Thorsten Klampfl, Michaela Prchal-Murphy, Sebastian Kollmann, Alessia Schirripa, Lisa Scheiblecker, Markus Zojer, Natalia Kunowska, Lea Gebrail and 10 more

Abstract read
In one paragraph

Article in Blood, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. AbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The role(s) of NF-Y in development and differentiation.Cell death and differentiation · 2025
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Isabella M MayerUniversity of Veterinary Medicine, Vienna, Vienna, Austria.ORCID 0000-0002-9164-9547
Eszter DomaUniversity of Veterinary Medicine, Vienna, Vienna, Austria.ORCID 0000-0003-2989-1022
Thorsten KlampflUniversity of Veterinary Medicine, Vienna, Vienna, Austria.ORCID 0000-0002-6666-9773
Michaela Prchal-MurphyUniversity of Veterinary Medicine, Vienna, Vienna, Austria.
Sebastian KollmannUniversity of Veterinary Medicine, Vienna, Vienna, Austria.ORCID 0000-0001-7911-9896
Alessia SchirripaUniversity of Veterinary Medicine, Vienna, Vienna, Austria.ORCID 0000-0001-5446-9136
Lisa ScheibleckerUniversity of Veterinary Medicine, Vienna, Vienna, Austria.
Markus ZojerUniversity of Veterinary Medicine, Vienna, Vienna, Austria.
Natalia KunowskaInstitute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Graz, Austria.
Lea GebrailUniversity of Veterinary Medicine, Vienna, Vienna, Austria.
Lisa E ShawDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2273-7655
Ulrike MannDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.
Alex FarrDepartment of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4628-9052
Reinhard GrausenburgerUniversity of Veterinary Medicine, Vienna, Vienna, Austria.
Gerwin HellerClinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Eva Zebedin-BrandlInstitute of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Matthias FarlikDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-0698-2992
Marcos MalumbresCancer Cell Cycle Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Veronika SexlUniversity of Veterinary Medicine, Vienna, Vienna, Austria.
Karoline KollmannUniversity of Veterinary Medicine, Vienna, Vienna, Austria.ORCID 0000-0002-7937-4245

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractHematopoietic stem cells (HSCs) are characterized by the ability to self-renew and to replenish the hematopoietic system. The cell-cycle kinase cyclin-dependent kinase 6 (CDK6) regulates transcription, whereby it has both kinase-dependent and kinase-independent functions. Herein, we describe the complex role of CDK6, balancing quiescence, proliferation, self-renewal, and differentiation in activated HSCs. Mouse HSCs expressing kinase-inactivated CDK6 show enhanced long-term repopulation and homing, whereas HSCs lacking CDK6 have impaired functionality. The transcriptomes of basal and serially transplanted HSCs expressing kinase-inactivated CDK6 exhibit an expression pattern dominated by HSC quiescence and self-renewal, supporting a concept, in which myc-associated zinc finger protein (MAZ) and nuclear transcription factor Y subunit alpha (NFY-A) are critical CDK6 interactors. Pharmacologic kinase inhibition with a clinically used CDK4/6 inhibitor in murine and human HSCs validated our findings and resulted in increased repopulation capability and enhanced stemness. Our findings highlight a kinase-independent role of CDK6 in long-term HSC functionality. CDK6 kinase inhibition represents a possible strategy to improve HSC fitness.

Indexed as

Cyclin-Dependent Kinase 6Hematopoietic Stem CellsAdult Stem CellsAnimalsCell DifferentiationCell ProliferationCell Self RenewalHematopoietic Stem Cell TransplantationHumansMiceMice, Inbred C57BLCDK6 protein, humanCdk6 protein, mouseCyclin-Dependent Kinase 6

Identifiers

PMID38684032
PMCPMC11302456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.